| Entry |
|
|---|
| Name |
Ranimustine (JAN/INN);
Cymerin (TN) |
|---|
| Formula |
C10H18ClN3O7
|
|---|
| Exact mass |
327.0833
|
|---|
| Mol weight |
327.72
|
|---|
| Structure |
|
|---|
| Class |
|
|---|
| Remark |
| Therapeutic category: | 4219 |
|
|---|
| Efficacy |
Antineoplastic, Alkylating agent |
|---|
| Target |
DNA
RNA |
|---|
| Interaction |
|
|---|
| Structure map |
| map07040 | Antineoplastics - alkylating agents |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01A ALKYLATING AGENTS
L01AD Nitrosoureas
L01AD07 Ranimustine
D01760 Ranimustine (JAN/INN) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
4 Agents affecting cellular function
42 Antineoplastics
421 Alkylating agents
4219 Others
D01760 Ranimustine (JAN/INN)
Drug groups [BR:br08330]
Antineoplastic
DG01677 Alkylating agent
DG01724 Nitrosourea
D01760 Ranimustine
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 21
1 C1y C 21.6593 -17.7529
2 C1y C 22.8743 -18.4486
3 C1y C 24.0860 -17.7420
4 C1y C 24.0792 -16.3454
5 O2x O 22.8642 -15.6496
6 C1y C 21.6561 -16.3502
7 C1b C 25.2850 -15.6489
8 O1a O 25.3018 -18.4362
9 O2a O 20.4420 -15.6526
10 O1a O 20.4490 -18.4563
11 O1a O 22.8799 -19.8488
12 C1a C 19.2310 -16.3554
13 N1b N 26.4941 -16.3490
14 C5a C 27.7033 -15.6489
15 N1c N 28.9125 -16.3490
16 C1b C 30.1217 -15.6489
17 O5a O 27.7033 -14.2488
18 N2b N 28.9125 -17.7491
19 C1b C 31.3350 -16.3475
20 O3a O 27.6761 -18.4627
21 X Cl 32.5395 -15.6503
BOND 21
1 4 5 1
2 2 11 1 #Down
3 5 6 1
4 9 12 1
5 6 1 1
6 7 13 1
7 13 14 1
8 4 7 1 #Down
9 14 15 1
10 1 2 1
11 15 16 1
12 3 8 1 #Up
13 14 17 2
14 2 3 1
15 15 18 1
16 6 9 1 #Up
17 16 19 1
18 3 4 1
19 1 10 1 #Up
20 18 20 2
21 19 21 1
|
|---|
